Cargando…

Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status

BACKGROUND: Brain metastases (Bmets) are frequent; however, limited data exist on the efficacy of immunotherapy in these lesions. The aims of the study were to analyze the immunohistochemical expressions of programmed death ligand 1 (PD-L1) and CD8 in Bmets and to compare them with their expressions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camy, Florian, Karpathiou, Georgia, Dumollard, Jean Marc, Magne, Nicolas, Perrot, Jean Luc, Vassal, Francois, Picot, Tiphanie, Mobarki, Mousa, Forest, Fabien, Casteillo, Francois, Hathroubi, Sirine, Froudarakis, Marios, Peoc'h, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Immunotherapy Biomarkers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454240/ https://www.ncbi.nlm.nih.gov/pubmed/32859740 http://dx.doi.org/10.1136/jitc-2020-000597

Ejemplares similares

Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy
por: Karpathiou, Georgia, et al.
Publicado: (2020)

Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics
por: Karpathiou, Georgia, et al.
Publicado: (2016)

PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis
por: Yvorel, Violaine, et al.
Publicado: (2017)

The Premetastatic Lymph Node Niche in Gynecologic Cancer
por: Karpathiou, Georgia, et al.
Publicado: (2023)

CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
por: Duchemann, Boris, et al.
Publicado: (2022)

Primary central nervous system lymphomas express immunohistochemical factors of autophagy
por: Karpathiou, Georgia, et al.
Publicado: (2021)

Endobronchial melanoma metastasis 40 years after the excision of the primary cutaneous tumor: A case report
por: Karpathiou, Georgia, et al.
Publicado: (2017)

The Immune Microenvironment of Chordomas: An Immunohistochemical Analysis
por: Dridi, Maroa, et al.
Publicado: (2021)

Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
por: Karpathiou, Georgia, et al.
Publicado: (2021)

CD80 Expressed by CD8(+) T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8(+) T Cells
por: Rollins, Meagan R., et al.
Publicado: (2017)

The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review
por: Désage, Anne-Laure, et al.
Publicado: (2021)

Immune Escape Is an Early Event in Pre-Invasive Lesions of Lung Squamous Cell Carcinoma
por: Laville, David, et al.
Publicado: (2020)

Crystal-Storing Histiocytosis: The Iceberg of More Serious Conditions
por: Mobarki, Mousa, et al.
Publicado: (2023)

Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
por: Ma, Ke, et al.
Publicado: (2020)

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
por: Banchereau, Romain, et al.
Publicado: (2021)

Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
por: Niogret, Julie, et al.
Publicado: (2021)

Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology
por: Karpathiou, Georgia, et al.
Publicado: (2022)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1− Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy
por: Miracco, Clelia, et al.
Publicado: (2021)

Deciphering Microenvironment of NSCLC based on CD8+ TIL Density and PD-1/PD-L1 Expression
por: Lin, Ziying, et al.
Publicado: (2019)

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
por: Fumet, Jean-David, et al.
Publicado: (2018)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

Brain Metastases from Gynecologic Malignancies
por: Karpathiou, Georgia, et al.
Publicado: (2022)

Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD‐L1
por: Schachtele, Scott J., et al.
Publicado: (2014)

Classification of gallbladder cancer by assessment of CD8(+) TIL and PD-L1 expression
por: Lin, Jianzhen, et al.
Publicado: (2018)

Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer
por: Ghiringhelli, François, et al.
Publicado: (2023)

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
por: Fumet, Jean-David, et al.
Publicado: (2019)

The Predictive Value of CD3+/CD8+ Lymphocyte Infiltration and PD-L1 Expression in Colorectal Cancer
por: Liu, Jihong, et al.
Publicado: (2023)

PD-1(+)CD8(+) T Cells Proximal to PD-L1(+)CD68(+) Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
por: Yang, Xiaobao, et al.
Publicado: (2023)

TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance
por: Baas, Marije, et al.
Publicado: (2016)

Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer
por: Aghajani, Marra Jai, et al.
Publicado: (2020)

Lymphatic PD-L1 Expression Restricts Tumor-Specific CD8(+) T-cell Responses
por: Cousin, Nikola, et al.
Publicado: (2021)

Chemotherapy-induced changes in bronchoalveolar lavage fluid CD4 + and CD8 + cells of the opposite lung to the cancer
por: Karpathiou, Georgia, et al.
Publicado: (2020)

Circulating memory PD-1(+)CD8(+) T cells and PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
por: Liu, Jiang, et al.
Publicado: (2023)

EBV(+) and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8(+) Intratumoral Lymphocytes
por: De Rosa, Simona, et al.
Publicado: (2018)

The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8(+) T Cells During an Acute Retroviral Infection
por: David, Paul, et al.
Publicado: (2019)

PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8(+) T cell Induced Death
por: Suarez, Guadalupe Verónica, et al.
Publicado: (2019)

Correlation between schistosomiasis and CD8+ T cell and stromal PD-L1 as well as the different prognostic role of CD8+ T cell and PD-L1 in schistosomal-associated colorectal cancer and non-schistosomal-associated colorectal cancer
por: Wang, Weixia, et al.
Publicado: (2021)

Association of tumour and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with DCB and OS to nivolumab treatment in NSCLC patients pre-treated with chemotherapy
por: Niemeijer, Anna-Larissa Nadia, et al.
Publicado: (2020)

Niche-specific MHC II and PD-L1 regulate CD4(+)CD8αα(+) intraepithelial lymphocyte differentiation
por: Moon, Sookjin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oi86cq8jh5720k22hcdnulhfr6